Business

Gene-Sequencing Company Illumina to Sell Cancer Test Developer

Posted on by admin

The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.

Leave a Reply

Your email address will not be published. Required fields are marked *